Park Ha Biological Technology ratios data for the quarter ended Apr 2026. These financial ratios cover 5 quarters of results from Oct 2023 through Apr 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Oct2023 | Oct2024 | Apr2025 | Oct2025 | Apr2026 |
|---|---|---|---|---|---|
| Efficiency | |||||
| Inventory AverageInventory Avg. | 0.08M | 0.07M | 0.07M | 0.09M | |
| Assets AverageAssets Avg. | 2.67M | 4.46M | 5.89M | 6.71M | |
| Invested CapitalInvested Cap. | 1.02M | 3.02M | 4.31M | 0.88M | 1.96M |
| Asset Utilization RatioAsset Util. | 0.00 | -0.01 | |||
| Leverage & Solvency | |||||
| Debt Ratio | 0.00 | 0.49 | 0.01 | -0.52 | -0.46 |
| Valuation | |||||
| Price to SalesP/S | 0.00M | -1.48 | |||
| Price to BookP/B | 10.53 | 0.40 | 0.02 | ||
| Enterprise Value | 43.40M | -2.21M | -5.56M | ||
| Market Capitalization | 44.75M | 1.59M | 0.09M |